Diagnostyka Statistics

Total Valuation

Diagnostyka has a market cap or net worth of PLN 5.69 billion. The enterprise value is 6.67 billion.

Market Cap	5.69B
Enterprise Value	6.67B

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Diagnostyka has 33.76 million shares outstanding.

Current Share Class	33.76M
Shares Outstanding	33.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	15.17%
Float	n/a

Valuation Ratios

The trailing PE ratio is 21.31 and the forward PE ratio is 17.60. Diagnostyka's PEG ratio is 0.55.

PE Ratio	21.31
Forward PE	17.60
PS Ratio	2.48
PB Ratio	11.10
P/TBV Ratio	n/a
P/FCF Ratio	15.94
P/OCF Ratio	10.98
PEG Ratio	0.55

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.83, with an EV/FCF ratio of 18.70.

EV / Earnings	25.00
EV / Sales	2.90
EV / EBITDA	11.83
EV / EBIT	17.90
EV / FCF	18.70

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.96.

Current Ratio	0.73
Quick Ratio	0.62
Debt / Equity	1.96
Debt / EBITDA	1.78
Debt / FCF	2.82
Interest Coverage	5.72

Financial Efficiency

Return on equity (ROE) is 60.79% and return on invested capital (ROIC) is 16.73%.

Return on Equity (ROE)	60.79%
Return on Assets (ROA)	13.51%
Return on Invested Capital (ROIC)	16.73%
Return on Capital Employed (ROCE)	26.17%
Revenue Per Employee	293,179
Profits Per Employee	34,064
Employee Count	7,836
Asset Turnover	1.33
Inventory Turnover	11.10

Taxes

In the past 12 months, Diagnostyka has paid 55.42 million in taxes.

Income Tax	55.42M
Effective Tax Rate	16.68%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	182.81
200-Day Moving Average	170.64
Relative Strength Index (RSI)	40.08
Average Volume (20 Days)	61,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diagnostyka had revenue of PLN 2.30 billion and earned 266.93 million in profits. Earnings per share was 7.91.

Revenue	2.30B
Gross Profit	1.77B
Operating Income	372.80M
Pretax Income	332.30M
Net Income	266.93M
EBITDA	454.32M
EBIT	372.80M
Earnings Per Share (EPS)	7.91

Full Income Statement

Balance Sheet

The company has 37.44 million in cash and 1.01 billion in debt, giving a net cash position of -968.08 million or -28.68 per share.

Cash & Cash Equivalents	37.44M
Total Debt	1.01B
Net Cash	-968.08M
Net Cash Per Share	-28.68
Equity (Book Value)	512.26M
Book Value Per Share	14.67
Working Capital	-134.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 518.26 million and capital expenditures -161.49 million, giving a free cash flow of 356.78 million.

Operating Cash Flow	518.26M
Capital Expenditures	-161.49M
Free Cash Flow	356.78M
FCF Per Share	10.57

Full Cash Flow Statement

Margins

Gross margin is 77.09%, with operating and profit margins of 16.23% and 11.62%.

Gross Margin	77.09%
Operating Margin	16.23%
Pretax Margin	14.46%
Profit Margin	11.62%
EBITDA Margin	19.78%
EBIT Margin	16.23%
FCF Margin	15.53%

Dividends & Yields

This stock pays an annual dividend of 3.31, which amounts to a dividend yield of 2.06%.

Dividend Per Share	3.31
Dividend Yield	2.06%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	41.86%
Buyback Yield	n/a
Shareholder Yield	2.06%
Earnings Yield	4.69%
FCF Yield	6.27%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diagnostyka has an Altman Z-Score of 4.34 and a Piotroski F-Score of 5.

Altman Z-Score	4.34
Piotroski F-Score	5